driven by the PitchBook Platform
Developer of a vaccine against urinary tract infection. The company's vaccines are based on its proprietary peptide chemistry technology.
You’re viewing a free company profile from the PitchBook Platform. To explore Ariavax’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.